SMPDL3B and focal segmental glomerulosclerosis: The study conducted by Yoo et al. investigated the role of the enzyme sphingomyelinase-like phosphodiesterase 3b (SMPDL3b) in podocyte injury in glomerular diseases, including FSGS.